Get reviews centered on claims, experimental methods, reported results, limitations, and reproducibility criteria.Know what the science actually supports before you trust the answer.
Press Enter ↵ to request review
Explore by Goal
"Study hard what interests you the most in the most undisciplined, irreverent and original manner possible."
- Richard Feynman
Quick Answer
Copied
BRCA2 TR2 stabilizes RAD51 filaments by “bridging” across neighboring protomers
In in vitro reconstituted human RAD51 nucleoprotein filaments, the BRCA2 TR2 C-terminal motif binds an acidic-patch helix (RAD51 D184/D187) and simultaneously reaches across the protomer–protomer interface, acting as a brace that helps prevent destabilization/disassembly. Key interface residues are validated by mutagenesis and cross-linking, while cryoEM provides the structural placement of TR2 on the filament exterior ().
Long Answer
Paper review (structural mechanism)
Target paper:Structural basis for stabilisation of the RAD51 nucleoprotein filament by BRCA2(10.1038/s41467-023-42830-1)
Numbers below are taken directly from the manuscript’s cryoEM processing descriptions ().
Visual 2 — Mechanism schematic (what the structure implies)
A simplified mechanism map that stays within what the paper explicitly describes: (i) TR2 binds an exposed acidic-patch groove on RAD51; (ii) TR2 also contacts the protomer–protomer self-association region of the adjacent protomer; (iii) TR2 “bridges” across the protomer interface and thereby braces filament architecture ().
TR2–RAD51 “brace” model
Step A: acidic patch recognition
RAD51 acidic-patch helix residues D184 and D187 are required for TR2 binding (and also contribute to BRC4 binding).
Validated by EMSA + SPR + mutagenesis
Step B: cross-interface “brace”
TR2 binds across adjacent protomers at the filament exterior: part of TR2 contacts the acidic-patch groove on one protomer, while another segment reaches into the protomer interface of the neighboring protomer.
Step C: functional consequence
TR2-stabilized filaments are resistant to disassembly promoted by BRC4; mutating TR2 interface residues disrupts TR2 binding to filaments and therefore weakens the stabilization mechanism.
Core results (organized as evidence chain)
Below, I separate what the paper measures from what it infers, and I flag where mechanistic claims depend on structural interpretation.
1) Acidic patch is a shared recruitment hub (TR2 and BRC4)
Measured: RAD51 acidic-patch mutations (D184A and D184A/D187A) reduce TR2-dependent filament stabilization/aggregate formation in EMSA, and reduce TR2 binding in SPR; the effect is stronger when filaments are assembled on ssDNA.
Measured: The same acidic patch is required for BRC4’s ability to disrupt RAD51 nucleoprotein filament formation (EMSA) and established-filament disruption (SPR processing of BRC4 titrations).
Reasoning: Because both motifs use the same surface “hub,” overlap in their footprints supports the known biochemical observation that TR2 protects filaments from BRC4-mediated disassembly.
Critical note
Potential blind spot: The experiments use purified proteins and peptides and reconstitute nucleoprotein filaments on ssDNA/dsDNA substrates. That supports the biochemical interface model strongly, but it does not fully reproduce cellular regulation such as chromatin context, mediator competition, replication fork mechanics, and post-translational network effects.
2) TR2 induces bundling; mSA-capped DNA enables structure determination
Measured: Incubation of TR2 with RAD51 filaments causes extensive bundling/aggregation of filaments for both ss- and dsDNA substrates.
Engineering workaround: The authors reduce bundling by capping both ends of DNA with mono-streptavidin (mSA), allowing cryoEM particle picking without severe aggregation while maintaining TR2 binding.
Critical note
Possible limitation: mSA end-capping and steric constraints can alter the filament’s effective boundary conditions and possibly its packing. The authors do confirm that mSA-capped filaments remain TR2-binding competent, but it still means the cryoEM structure reflects a particular reconstituted architecture rather than every in vivo filament context.
3) CryoEM places TR2 as a bipartite interface ligand across protomers
Measured structurally: TR2 density decorates the outside surface; BRCA2 residues 3289–3304 can be modeled at the TR2–RAD51 interface, with no appreciable difference in binding mode between ssDNA vs dsDNA contexts (in their reconstructions).
Mechanistic geometry: TR2 uses a bipartite binding mode: a basic stripe (K3296/Q3299/R3302) complements acidic patch D184/D187, and additional TR2 residues reach to the protomer interface, forming contacts that “shield” self-association residues mediating protomer–protomer coupling.
Regulation hook: TR2 residue S3291 is positioned to hydrogen-bond to RAD51 E91, and the authors connect this to CDK-dependent regulation previously described for S3291.
Measured: TR2 basic-patch charge-reduction mutants (K3296A, Q3299A, R3302A) alter TR2 binding to RAD51 filaments; a triple alanine “3A” mutant and “3D” charge reversal abolish/break binding strongly.
Measured: F3298A abolishes TR2 binding, consistent with hydrophobic packing being essential.
Measured: S3291A reduces TR2 binding dramatically but does not eliminate binding completely (so S3291 is not the sole determinant of binding in this architecture).
Orthogonal support: Cross-linking: RAD51 S181C forms a disulfide-crosslinked species with TR2 C3304 under mild oxidation, supporting that those residues are spatially close at the interface.
Reasonable counterpoints / known unknowns (skeptical checklist)
These items are about what could falsify the paper’s mechanistic story or limit its scope, without adding external speculation beyond what is inferable from the provided full text.
Claim type
What supports it (from paper)
Main uncertainty / what would change it
Structural placement
CryoEM maps show density attributable to TR2 and allow modelling residues 3289–3304 at the TR2–RAD51 interface ()
Local resolution at the TR2 site is described as lower than global maps, which can make the exact register of flexible peptide portions more model-dependent; additional validation (e.g., more extensive mutational sweep along predicted register) could narrow uncertainty ()
Functional inference from binding
TR2 stabilizes filaments in EMSA and binding is reduced by TR2 interface mutations; acidic patch mutants reduce TR2 binding and impair BRC4 filament disruption ()
Mechanistic links to in vivo replication fork protection require caution: the work uses truncated TR2 constructs/MBP fusions and defined DNA templates; cellular factors could alter stoichiometry, competition, and filament dynamics ()
Disassembly/bracing mechanism
TR2 binding footprint overlaps with BRC4 footprint, and TR2 is proposed to brace protomers and protect against BRC4-mediated destabilization ()
The “brace” model is strongly supported by geometry + binding/disruption assays, but it is still an inference about dynamic stabilization over time; direct measurements of filament lifetime under load (or with full BRCA2/other replisome components) would sharpen or falsify the dynamic aspect ()
Evidence-based takeaways for a researcher
Interface map: RAD51 D184/D187 acidic patch is a recruitment hub for both BRCA2 TR2 and BRC4, linking the two motifs mechanistically through a shared surface ().
Mechanistic geometry: TR2 is bipartite—one region engages the acidic groove on a protomer while another region reaches into the neighboring protomer interface, consistent with a protomer “brace” stabilizing filament architecture ().
Model validation: Multiple interface mutations (charge reversal/charge reduction, hydrophobic packing disruption) reduce binding and cross-linking (RAD51 S181C ↔ TR2 C3304) supports spatial proximity at the proposed interface ().
Author reviews (direct links)
Use these to compare peer perspectives against the structural evidence.
Data availability: cryoEM coordinates/maps deposited at PDB/EMDB with accessions PDB 8PBC & 8PBD and EMDB 17584 & 17585 ().
Feedback:
Updated: July 12, 2026
BGPT Paper Review
Study Novelty
90%
High-resolution cryoEM and structure-guided mutational validation together provide the missing structural basis for how BRCA2’s TR2 motif binds and stabilizes RAD51 filaments—previous models described binding biochemistry but lacked atomic placement on the filament ().
Scientific Quality
90%
The study uses an evidence-complete pipeline (biochemical binding/stability measurements, interface mutagenesis, cryoEM with density-guided modeling, and orthogonal cross-linking) and deposits coordinates/maps in PDB/EMDB, supporting scrutiny and reuse (). Potential quality caution: local resolution at the TR2 site is lower than global maps, which can increase model-register uncertainty (acknowledged by the authors) ().
Study Generality
80%
Mechanistic principles (motif docking to an acidic patch; bridging across protomer interface) plausibly generalize across mediator recruitment strategies, and the paper discusses an evolutionarily conserved hub used by fission yeast Rad51 mediators; however, the direct experimental basis here is human proteins and specific in vitro reconstitutions, leaving some generality dependent on future in vivo/stoichiometry validation ().
Study Usefulness
80%
Practical utility is high for structural mechanistic work: it pinpoints the TR2–RAD51 groove/interface and provides residue-level constraints that can guide future mutagenesis or small-molecule/inhibitor design targeting the interaction surface ().
Study Reproducibility
80%
The manuscript provides detailed descriptions of constructs, purification approach (citing prior RAD51 purification), DNA oligos, EMSA/SPR/cross-linking procedures, cryoEM acquisition and processing choices, and public PDB/EMDB accession codes (8PBC/8PBD; 17584/17585) (). Remaining reproducibility uncertainty: the excerpted content signals that local resolution limitations affected peptide fitting; exact modelling decisions may require access to supplementary details not shown here ().
Explanatory Depth
90%
The paper provides a cohesive mechanistic explanation linking (i) an acidic patch hub, (ii) bipartite TR2 binding geometry across protomers, and (iii) experimentally observed effects on binding/stabilization and competition with BRC4, with structural placement anchored by cryoEM and interface residue validation ().
Parses the paper’s reported cryoEM metadata (PDB/EMDB accessions, resolutions, particle counts) and generates plots comparing ssDNA vs dsDNA TR2 structures and their processing scale.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
A pure electrostatic attraction model (“acidic patch binds TR2 basic residues” without protomer-bridge geometry) is less likely because cryoEM explicitly shows TR2 reaching across the protomer interface and mutating interface/hydrophobic residues (e.g., F3298A) abolishes binding rather than merely weakening it ().
Assuming that S3291 is the sole binding determinant would be incorrect: S3291A still permits measurable binding, while other residues (e.g., hydrophobic F3298 and the charge cluster 3A/3D) are described as near-complete binding disruptors in their assays ().
Quick Answer
Long Answer
Top Data Sources
ExportMCP
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
